In yeast, anaphase entry depends on Pds1 proteolysis, while chromosome re-duplication in the subsequent S-phase involves degradation of mitotic cyclins such as Clb2. Sequential proteolysis of Pds1 and mitotic cyclins is mediated by the anaphase-promoting complex (APC). Lagging chromosomes or spindle damage are detected by surveillance mechanisms (checkpoints) which block anaphase onset, cytokinesis and DNA re-replication. Until now, the MAD and BUB genes implicated in this regulation were thought to function in a single pathway that blocks APC activity. We show that spindle damage blocks sister chromatid separation solely by inhibiting APC Cdc20 -dependent Pds1 proteolysis and that this process requires Mad2. Blocking APC Cdh1 -mediated Clb2 proteolysis and chromosome re-duplication does not require Mad2 but a different protein, Bub2. Our data imply that Mad1, Mad2, Mad3 and Bub1 regulate APC Cdc20 , whereas Bub2 regulates APC Cdh1 .
Introduction
The duplication of chromosomes, the separation of sister chromatids and their segregation to opposite poles of the cell prior to cytokinesis are essential features of the eukaryotic cell cycle. Cells possess regulatory mechanisms that initiate these events in the correct order and that render cell cycle progression dependent on successful completion of preceding events. These mechanisms ensure that chromosome duplication occurs only once per cell cycle, and that it alternates with the processes of sister chromatid separation and cytokinesis. Furthermore, these mechanisms contribute to the high fidelity of chromosome transmission by providing additional time to repair DNA damage or to complete assembly of the mitotic apparatus.
The chromosome cycle starts with DNA replication, whose initiation takes place in two steps. Assembly of replication-competent complexes at future origins occurs upon inactivation of mitotic cyclin-dependent kinases (CDKs) as cells exit from mitosis, whereas the emergence of replication forks from these origins only occurs upon activation of S phase-promoting CDKs in late G 1 (Tanaka and Nasmyth, 1998) . Chromosome duplication produces a pair of sister chromatids bound together by a multisubunit Cohesin complex (Guacci et al., 1997; Michaelis et al., 1997; Losada et al., 1998) which forms joints between sisters during the process of replication (Uhlmann and Nasmyth, 1998) . Cohesin holds sisters together throughout G 2 and subsequently during their alignment on the mitotic spindle when it opposes the splitting force exerted by the spindle. In yeast, the eventual separation of sister chromatids during anaphase is thought to be triggered by dissolution of the linkage between sisters mediated by Cohesin. Scc1, an essential subunit of Cohesin, disappears from chromosomes at the point of their separation (Michaelis et al., 1997) . Furthermore, this process depends on a sister separating protein (Separin) called Esp1, which is essential for sister chromatid separation but not for other anaphase events .
Sister chromatid separation and chromosome re-duplication both depend on proteolysis of regulatory molecules. In budding yeast, sister chromatid separation depends on proteolysis of Pds1 (Cohen-Fix et al., 1996) , which binds to and inhibits Esp1 . Assembly of replication-competent complexes on origins, the first step in chromosome re-duplication, involves proteolysis of B-type cyclins such as Clb2, Clb3 and Clb5 (Nasmyth, 1996) . Degradation of all these proteins depends on a ubiquitin protein ligase called the anaphase-promoting complex (APC) or cyclosome (Irniger et al., 1995; King et al., 1995; Sudakin et al., 1995) . However, proteolysis of different APC substrates commences at different stages of mitosis and depends on different activator proteins. Pds1 destruction occurs shortly before the onset of anaphase and depends on Cdc20 (Visintin et al., 1997) , whereas Clb2 destruction only occurs later during anaphase and depends on a different, but related activator called Cdh1 or Hct1 (Schwab et al., 1997; Visintin et al., 1997) .
To avoid missegregation of chromosomes, anaphase must only be initiated after sister chromatids of each duplicated chromosome have attached to opposite poles of the mitotic spindle. Microtubules emanating from opposing spindle poles attach to a specialized structure on each sister chromatid called the kinetochore. Microtubules are thought to 'find' kinetochores by a 'search and capture' mechanism which cannot be completed simultaneously for all chromosomes (Hayden et al., 1990; Merdes and De Mey, 1990) . Cells therefore possess regulatory mechanisms that delay sister chromatid separation, cytokinesis and chromosome re-duplication until the last chromosome has achieved bipolar attachment. Mechanisms required to enforce the dependency of cell cycle progression on the completion of previous steps have been termed surveillance mechanisms or checkpoints (Hartwell and Weinert, 1989) . Similar if not identical mechanisms block cell cycle progression after the artificial destruction of the spindle by microtubule-depolymerizing drugs such as nocodazole or benomyl. Neither Pds1 nor Clb2 are degraded when cells are treated with nocodazole, presumably because mitotic surveillance mechanisms inhibit the APC.
The isolation of mutants that die rapidly when treated with drugs such as nocodazole has identified several genes thought to be involved in mitotic surveillance: MAD1, MAD2, MAD3, BUB1, BUB2, BUB3, PDS1 and MPS1 (Hoyt et al., 1991; Li and Murray, 1991; Weiss and Winey, 1996; Yamamoto et al., 1996) . These mutants have been shown to be defective in halting various aspects of the cell cycle in the absence of mitotic spindles, at least after long periods in the presence of nocodazole. MAD1, MAD2, MAD3, BUB1 and BUB3 have homologues in multicellular eukaryotes, including humans (Chen et al., , 1998 Li and Benezra, 1996; Pangilinan et al., 1997; Jin et al., 1998; Taylor et al., 1998) . Interestingly, vertebrate homologues of Mad2, Bub1 and Bub3 were found to associate with kinetochores prior to chromosome alignment on the metaphase plate Li and Benezra, 1996; Taylor and McKeon, 1997; Taylor et al., 1998) . The immunolocalization to kinetochores is lost after chromosomes become properly attached to the mitotic spindle at metaphase, suggesting that these proteins might monitor the completeness of the spindle-kinetochore attachment. Mad proteins were also found to be directly involved in blocking cell cycle progression. Mad2 and Mad3 bind to Cdc20 and, furthermore, Cdc20 mutants defective in Mad2 association allow cells to escape from the mitotic arrest . These yeast data, together with data from the study of human Mad2 (Fang et al., 1998) , suggest that Mad proteins block sister chromatid separation by inhibiting the activity of APC Cdc20 . It is unclear, however, whether the same proteins also inhibit APC Cdh1 and, moreover, how Bub proteins contribute to cell cycle arrest.
It is currently thought that sister chromatid separation might be triggered by Pds1 proteolysis. Expression of a non-degradable version of Pds1 does indeed block entry into anaphase (Cohen-Fix et al., 1996) . However, a dependence of sister separation on Pds1 destruction does not necessarily imply that Pds1 destruction is therefore rate limiting for sister separation in wild-type cells. Indeed, deletion of PDS1 is not lethal, at least when cells are grown at low temperatures. Other mechanisms clearly exist that are capable of regulating the metaphase to anaphase transition in yeast.
The main task of biology is to determine how wildtype cells function. Might Pds1 destruction be the ratelimiting step in wild-type cells? To address this question, we compared the kinetics of sister separation in wild-type and pds1 mutants. Somewhat to our surprise, we found little or no difference. This suggests that a Pds1-independent mechanism contributes to the timing of anaphase onset in wild-type yeast cells. What then is Pds1's main role in the yeast cell cycle? Why do yeast cells subjugate the segregation of their chromosomes by the need to degrade Pds1? It appears that cell cycle arrest in response to DNA or spindle damage depends on Pds1; that is, cells arrest nuclear division by blocking Pds1 destruction (Yamamoto et al., 1996; Cohen-Fix and Koshland, 1997) . We therefore investigated further the mechanism by which Mad proteins and Pds1 block sister chromatid separation when spindles are severely damaged by nocodazole. It has already been 2708 shown that sister separation occurs in~50% of pds1 mutant cells after 5 h incubation in nocodazole (Yamamoto et al., 1996) . This observation does not, however, exclude the possibility that pds1 mutant cells are capable of delaying sister separation for several hours (i.e. for up to one generation time). We therefore measured the response of pds1 and mad mutants to nocodazole using cells synchronized by centrifugal elutriation. Our data suggest that Mad proteins block sister separation solely by inhibiting Pds1 proteolysis and that this alone is responsible for inhibiting Esp1. They therefore confirm what till now had merely been a reasonable working hypothesis. However, contrary to previous conclusions, Mad proteins are not required to block Clb2 degradation and chromosome rereplication. These processes are regulated by Bub2, which has little or no direct role in the regulation of Pds1 proteolysis. Our data suggest that proteolysis mediated by APC Cdc20 and APC Cdh1 is regulated by different proteins. Mad proteins are largely concerned with blocking sister chromatid separation, whereas Bub2 is concerned with blocking exit from mitosis, cytokinesis and chromosome re-duplication.
Results

MAD2 but not BUB2 is essential for blocking Pds1 degradation in cells treated with nocodazole
Pds1 degradation, mediated by APC Cdc20 , is an essential pre-condition for sister chromatid separation (Cohen-Fix et al., 1996) . Mad2 binds APC Cdc20 and inactivates it upon nocodazole treatment (Fang et al., 1998; Hwang et al., 1998) . To address whether spindle checkpoint proteins arrest the cell cycle by blocking Pds1 proteolysis, we compared the kinetics of Pds1 degradation in wild-type, mad2 and bub2 deletion strains as small G 1 cells were incubated at 25°C in the presence of nocodazole. The drug completely blocked Pds1 degradation in wild-type cells ( Figure 1A ) but had no effect in mad2 mutant cells; Pds1 disappeared from nuclei with kinetics similar if not identical to those observed in wild-type cells grown in the absence of nocodazole ( Figure 1B ). In contrast, BUB2 was not required to block Pds1 degradation ( Figure 1C ), indicating that Bub2 has a different role than Mad2 in the spindle checkpoint arrest. We conclude that in cells treated with nocodazole, Mad2 but not Bub2 is essential for blocking degradation of Pds1.
Mad2 and Pds1 are essential for blocking dissociation of Scc1 from chromosomes in cells treated with nocodazole
We next asked whether Mad2 is essential for regulating sister chromatid separation when spindles are damaged. Minshull et al. (1996) have already reported that 50% of mad2 mutant cells fail to hold sister chromatids together when incubated in nocodazole. By visualizing the chromosomes using a tet repressor-green fluorescent protein fusion (tetR-GFP) which binds to an array of tet operators integrated near the centromere of chromosome V (Michaelis et al., 1997) , we were not able to detect more than 30% cells with separated GFP 'dots' and only after a long incubation in nocodazole. To avoid the risk of underestimating the efficiency of sister chromatid separation by measuring the physical separation of sisters in cells that possess no means of pulling them apart, we analysed the chromosomal association of an epitopetagged variant of Scc1 (Scc1-myc18) using 'chromosome spreads'. Scc1 is essential for establishment and maintenance of sister chromatid cohesion and suddenly disappears from chromosomes at the time of their separation (Michaelis et al., 1997) . Recent data suggest that the disappearance of Scc1 from chromosomes is synonymous with loss of sister chromatid cohesion (F.Uhlmann and K.Nasmyth, personal communication). Scc1's association with chromosomes was analysed as G 1 cells of a mad2 deletion strain progressed through the cell cycle at 25°C, in both the absence and presence of nocodazole. The drug completely blocks Scc1 dissociation in wild-type cells (Uhlmann and Nasmyth, 1998) , but it had no effect on the kinetics of this process in mad2 mutant cells ( Figure  2A and B).
To test whether Mad2's role in inhibiting Scc1 dissociation from chromosomes is limited to blocking Pds1 proteolysis, we analysed Scc1's disappearance from chromatin as G 1 cells from a pds1 deletion strain progressed through the cell cycle at 25°C, and we observed that nocodazole failed to delay Scc1's dissociation from chromosomes ( Figure 2C and D) . We conclude that both MAD2 and PDS1 are essential for blocking Scc1's disappearance from chromosomes when spindles are damaged by nocodazole. Our data suggest that Mad2 blocks sister chromatid separation exclusively by blocking proteolysis of Pds1, which binds to and inhibits the sister separating protein Esp1. Despite being completely defective in arresting sister chromatid separation, mad2 mutant cells were capable of preventing cytokinesis and DNA re-replication ( Figure 2B ). This finding demonstrates that the Mad2-dependent surveillance mechanism inhibits a subset of the events that are blocked by damaging spindles. Mad2's role in arresting the cell cycle is therefore more specific than hitherto suspected (Minshull et al., 1996) .
Cell cycle arrest due to over-expression of MPS1 depends on PDS1 Our analysis of Scc1 circumvented the problems associated with measuring sister separation accurately in cells that possess no spindle apparatus. We wished nevertheless to assess more directly Pds1's role in blocking sister separation. The activation of the spindle checkpoint without inducing spindle damage by over-production of the Mps1 protein-kinase provided a suitable opportunity. Overexpression of MPS1 causes a MAD/BUB-dependent cell cycle arrest in cells with functional spindles (Hardwick et al., 1996) . If Pds1 were the sole means by which Mad/ Bub proteins block sister separation, then cell cycle arrest mediated by GAL-MPS1 should be dependent on PDS1. To test this, small G 1 cells of wild-type and pds1 mutant strains over-expressing MPS1 from the GAL promoter were isolated by centrifugal elutriation and released into galactose medium. Mps1 over-production completely blocked anaphase entry in wild-type cells ( Figure 3A ), but it had no effect on nuclear division and the formation of anaphase spindles in pds1 mutant cells ( Figure 3B ). These data confirm that Pds1 is essential to block entry into anaphase upon activation of the spindle checkpoint.
Pds1 is not required to prevent precocious sister chromatid separation during a normal cell cycle
The fact that Pds1 is destroyed shortly before sisters separate (Michaelis et al., 1997) suggests that Pds1 proteolysis might actually trigger the metaphase to anaphase transition, in which case pds1 mutants should separate sister chromatids precociously. To test this, we compared the kinetics with which sequences adjacent to centromere V (CenV) separated in wild-type and pds1 deletion strains as small G 1 cells isolated by centrifugal elutriation were incubated at 25°C. CenV sequences, visualized using the tetR-GFP/tet operator system, separated with similar kinetics~60 min after bud emergence in both strains ( Figure 4A and B). This suggests that sister separation is controlled by a second mechanism which does not involve Pds1. This Pds1-independent mechanism does not depend on MAD2, because sister separation occurred with similar kinetics in mad2 single mutants ( Figure 4C ) and in pds1mad2 double mutants ( Figure 4D ).
Neither Mad2 nor Pds1 are required to delay Clb2 proteolysis in nocodazole-arrested cells
Cytokinesis and DNA re-replication are known to depend on inactivation of Cdk1 kinases (Surana et al., 1993; Dahmann et al., 1995) . The failure of mad2 mutant cells to undergo cytokinesis and re-replication therefore suggests that these cells maintain Cdk1 activity. To test this notion, we analysed the levels of Clb2 and Clb3 following incubation of small G 1 cells of wild-type and mad2 mutants in the absence ( Figure 5A and C) and in the presence of nocodazole ( Figure 5B and D). The drug had no influence on the appearance of either protein.
Clb3 accumulated during S phase and Clb2 accumulated 15 min later. In the absence of nocodazole, Clb3 and Clb2 declined 65 and 80 min, respectively, after entry into S-phase. Clb2-associated Cdk1 kinase activity had a similar profile. In wild-type cells, nocodazole, as expected, blocked the degradation of both Clb2 and Clb3 ( Figure 5B ). Clb3 protein levels also dropped in mad2 mutants incubated in nocodazole, 80 min after cells initiated S-phase, but Clb2 levels and Clb2-associated kinase activity continued to accumulate for 1 h and only then started to decline, albeit very slowly ( Figure 5D ). We conclude that Mad2 is required to block degradation of Pds1 and, to a certain extent, also that of Clb3. However, Mad2 is not required to delay Clb2 proteolysis or inactivation of its associated Cdk1 kinase. A Mad2-independent mechanism must largely be responsible for blocking Clb2-Cdk1 kinase inactivation, cytokinesis and DNA re-replication.
We also measured the levels of Clb2 and Clb3 following incubation of G 1 pds1 mutant cells in nocodazole. We found that neither protein was degraded and that cells neither underwent cytokinesis nor re-replicated their chromosomes ( Figure 5E ). The previous observation that histone H1 kinase remains high several hours after incubation of pds1 mutants with nocodazole (Yamamoto et al., 1996) is consistent with our measurement of Clb2 and Clb3 levels.
Our finding that ജ95% of mad2 mutant cells maintain high levels of Clb2-Cdk1 kinase and fail to re-replicate their genomes in the presence of nocodazole is inconsistent with an earlier conclusion that Mad2 is necessary to block inactivation of Clb2-Cdk1 (Minshull et al., 1996) . In the latter study, cells were arrested with α-factor and released into medium containing nocodazole. We note, however, that Clb2-Cdk1 kinase did not drop more than 2-fold from its peak level in mad2 mutants and then persisted despite re-addition of α-factor. If cells were completely defective in blocking exit from mitosis they would be expected to arrest in G 1 and the Clb2-Cdk1 kinase should disappear. To address whether the method of synchronization might be responsible for our different results, we analysed the DNA content of wild-type and mad2 mutant cells after their release from α-factor. This confirmed that mad2 mutants delay cell cycle progression by at least one generation time even when synchronized by pheromone release: 3 h after release in the absence of nocodazole, wild-type cells underwent a second round of DNA replication, while the majority of mad2 mutant cells released in the presence of nocodazole are still arrested with 2C DNA content ( Figure 5F ). Upon longer incubation in nocodazole, a fraction of mad2 mutant cells indeed rereplicate their DNA which may account for the drop of Cdk1 activity observed by Minshull et al. (1996) .
Bub2 and Pds1 can block Clb2 degradation independently
As shown in Figure 1C , bub2 mutants treated with nocodazole block not only Pds1 proteolysis, but also cytokinesis and DNA re-replication, consistent with their ability to block Clb2 and Clb3 proteolysis and to maintain high levels of Clb2-associated-Cdc28 kinase activity ( Figure 6A ). One possibility is that Pds1, which persists in bub2 mutants, in addition to inhibiting Esp1, blocks Clb2 proteolysis by a mechanism that is independent of Bub2. This hypothesis is consistent with the observation that expression of a non-degradable version of Pds1 not only blocks sister chromatid separation but also Clb2 proteolysis (A.Toth, personal communication) . To test this, Clb2 and Clb3 protein levels were measured as small G 1 cells of a bub2pds1 double mutant strain were incubated in medium containing nocodazole at 25°C ( Figure 6B ). Both proteins were degraded and furthermore, the double mutant cells re-replicated their chromosomes, albeit more slowly than wild-type cells incubated in the absence of nocodazole (compare Figures 6B and 4A ). These data show that the block to Clb2 degradation in bub2 mutants is dependent on Pds1 and that the same block in pds1 mutants is dependent on Bub2. Thus, nocodazole blocks mitotic cyclin degradation and re-replication by two independent mechanisms: a Mad2-dependent pathway blocks Pds1 degradation and thereby that of Clb2, whereas a Bub2-dependent pathway blocks Clb2 degradation in a Pds1-independent manner. bub2mad2 double mutants re-replicate their DNA with wild-type kinetics in nocodazole Our data suggest that at least two different pathways respond to microtubule depolymerization by nocodazole: a Mad2-dependent pathway blocks Pds1 degradation and sister chromatid separation, whereas a Bub2-dependent pathway blocks Clb2 degradation and re-replication. To test whether inactivation of both pathways would completely abrogate cell cycle arrest due to nocodazole, we analysed cell cycle progression of bub2mad2 double mutant cells in the presence of nocodazole ( Figure 6C ).
We observed, remarkably, that these cells re-replicated their genomes with kinetics that were very similar to wildtype cells incubated in the absence of nocodazole. The double mutant cells also degraded Clb2 and Clb3 (with kinetics that were similar to wild-type cells incubated in the absence of nocodazole) and even underwent cytokinesis, producing cells with little or no DNA and cells with a 4C DNA content.
DNA re-replication in bub2mad2 double mutant cells was more efficient than in bub2pds1 double mutant cells (compare Figure 6B and C) , which suggests that Mad2 blocks proteolysis of proteins other than Pds1, whose persistence in bub2pds1 cells interferes with re-replication. A candidate for such a protein is Clb3, which is degraded in mad2 mutant cells treated with nocodazole ( Figure 5D ), but not in pds1 mutant cells in nocodazole ( Figure 5E ).
Bub2 functions in a pathway that is different to that of other Mad and Bub proteins
The efficient re-replication in the presence of nocodazole of bub2mad2 double mutants but not either single mutant suggests that Mad2 and Bub2 function in different regu-latory pathways. To assign other MAD and BUB genes to these two different pathways, we analysed the cellular DNA contents of various bubmad double mutants. We first established that it is possible to distinguish the behaviour of wild-type, mad and bub single mutants, and bub2mad2 double mutants by following the cellular DNA content of asynchronous cultures incubated for 3 h in the presence of nocodazole: wild-type and single mutant cells arrested with a 2C DNA content, whereas the bub2mad2 double mutant cells accumulated a 4C DNA content (Figure 7) . Consistent with previously published data (Schott and Hoyt, 1998) , a fraction of mad2, mad3 and bub2 single mutant cells re-replicated their DNA after longer incubation in nocodazole. bub1mad1, bub1mad2, mad1mad2 and mad2mad3 double mutants all resembled wild-type, but bub2mad3, bub2mad1 and bub1bub2 double mutants underwent re-replication (Figure 7 ). These data suggest that Mad1, Mad2, Mad3 and Bub1 all belong to the same regulatory pathway, which is distinct from that of Bub2.
The Bub2-dependent pathway is functional in cells carrying a Mad2-resistant allele of CDC20 Our conclusion that Mad2 and Bub2 can independently block cell cycle progression upon spindle checkpoint activation is apparently inconsistent with the existence of CDC20 alleles defective in blocking re-budding and DNA re-replication Schott and Hoyt, 1998) . To test whether CDC20-107 mutant cells are completely defective in the spindle checkpoint response we compared cellular DNA contents of CDC20-107 single mutants and CDC20-107 bub2 double mutants as elutriated G 1 cells progressed through the cell cycle in the presence of nocodazole. Few if any CDC20-107 mutant cells rereplicated their DNA within a period in excess of one generation time, similar to mad2 deletion mutants (compare Figures 8A and 1B) , while CDC20-107 bub2 double mutants efficiently re-replicated their DNA resembling bub2mad2 mutants (compare Figures 8B and 6C) . A crucial difference between our studies and previous ones is the time course over which cells have been observed: a fraction of the elutriated CDC20-107 single mutant cells also re-replicated after extended incubation in nocodazole (data not shown). These data confirm that unlike Mad2, Bub2 functions independently of Cdc20.
DNA re-replication in bub2mad2 double mutant cells treated with nocodazole depends on Cdc14
To maintain high levels of Cdk1 activity, Bub2 must regulate proteolysis of both Clb2 and the Cdk inhibitor Sic1. Therefore, it is unlikely that Bub2 inhibits the APC directly as does Mad2, but rather a protein that regulates both processes. A good candidate is the Cdc14 phosphatase, which is essential for inactivation of Clb2-Cdk1 at the end of mitosis (Fitzpatrick et al., 1998) . Cdc14 has been shown to de-phosphorylate Sic1 and Swi5, both of which would contribute to Sic1 accumulation (Visintin et al., 1998) . Cdc14 also de-phosphorylates Cdh1 (Jaspersen et al., 1999) , which would permit Cdh1 to bind to the APC and thereby activate Clb2 proteolysis . If this hypothesis is correct, then the re-replication of bub2mad2 double mutants in the presence of nocodazole should be dependent on Cdc14. To test this, nocodazole was added to wild-type, bub2mad2 double mutant and bub2mad2 cdc14-3 triple mutant cultures growing at 25°C. After 1 h, all three cultures were shifted from 25 to 36°C. Neither wild-type nor mad2bub2 cdc14-3 triple mutant cells re-replicated their DNA, whereas the mad2bub2 double mutants did ( Figure 9A ). This shows that loss of Mad2 and Bub2 does not bypass the need for Cdc14 during exit from mitosis. Cdc14 might therefore be Bub2's ultimate target.
Over-expression of TEM1 in mad2 mutant cells treated with nocodazole can bypass Bub2's block of DNA re-replication Another protein needed in addition to Cdc14 for mitotic exit is a GTP-binding protein encoded by TEM1. It is therefore interesting that Bub2 shares sequence similarity with Cdc16 from Schizosaccharomyces pombe, a GTPaseactivating protein (GAP) which regulates septum formation (Fankhauser et al., 1993) . This raises the possibility that Bub2 inhibits Cdk1 inactivation by inducing hydrolysis of GTP bound to Tem1. To test this, we compared the re-replication kinetics in the presence of nocodazole of wild-type, bub2mad2 double mutant and mad2 single mutant cells expressing an additional TEM1 gene from the GAL promoter. TEM1 over-expression was induced by addition of galactose to cells previously grown in raffinose medium, immediately after addition of nocodazole. We observed that TEM1 over-expression induced DNA re-replication in mad2 mutant cells ( Figure 9B) . Fig. 7 . Mad1, Mad2, Mad3 and Bub1 belong to a mitotic surveillance pathway distinct from the Bub2-dependent pathway. Strains were grown to exponential phase and cellular DNA was analysed at the indicated times after addition of nocodazole. The following strains were used: wild-type (K699), bub2Δ (K7145), mad2Δ (K7746), bub2Δmad2Δ (K7422), bub2Δmad3Δ (K7504), bub2Δmad1Δ (K7625), bub1Δbub2Δ (K7763), bub1Δmad1Δ (K7624), bub1Δmad2Δ (K7509), mad1Δmad2Δ (K7626), and mad2Δmad3Δ (K7501). bub1Δmad1Δ, bub1Δmad2Δ, mad1Δmad2Δ and mad2Δmad3Δ double mutants behaved similarly to wild-type, whereas bub2Δmad3Δ mutant cells rereplicated their DNA as efficiently as bub2Δmad2Δ mutant cells. Less efficient re-replication was observed in bub2Δmad1Δ and bub1Δbub2Δ mutant cells. This is consistent with the hypothesis that Bub2 blocks Cdk1 inactivation by inhibiting Tem1 activity.
The budding yeast homologue of Byr4 is part of the Bub2 checkpoint pathway byr4 ϩ is an essential gene regulating karyokinesis and cytokinesis in S.pombe (Song et al., 1996) . Byr4 binds to Cdc16 and Spg1, the S.pombe homologues of Bub2 and Tem1, in yeast two-hybrid assays, and in coimmunoprecipitations in vivo and in vitro (Furge et al., 1998; Jwa and Song, 1998) . In vitro, Cdc16 and Byr4 form a twocomponent GAP for the Spg1 GTPase and they appear to negatively regulate septation in S.pombe by modulating the nucleotide state of Spg1 (Furge et al., 1998) . Looking for putative Byr4 homologues in the budding yeast by sequence homology search, we have found YJR053W, a previously uncharacterized open reading frame (ORF). Unlike the S.pombe gene, the Saccharomyces cerevisiae counterpart is not essential for cell viability. If YJR053W were a real homologue of byr4 ϩ , one would expect it to have a role similar to BUB2 in regulation of the spindle checkpoint. To test this, nocodazole was added to asynchronous cultures of mad2bub2 double mutants, byr4 single mutants and byr4mad2 double mutants. After 3 h, byr4 single mutants showed a moderate checkpoint defect as scored by DNA re-replication, while the byr4mad2 double mutant cells exhibited the same strong checkpoint defect as bub2mad2 double mutants. These results suggest that YJR053W is necessary for the Bub2-dependent cell cycle arrest. It therefore appears to have a role similar to S.pombe byr4 ϩ , which prompted us to adopt the same name. (K699), bub2Δmad2Δ (K7422) and bub2Δmad2Δ cdc14-3 (K7744) were treated with nocodazole (15 μg/ml) at time point zero, and after 1 h the temperature was increased from 25 to 36°C in order to inactivate the temperature-sensitive cdc14-3 allele. The cellular DNA content was measured by flow cytometry and it indicates that inactive Cdc14 can block DNA re-replication in cells lacking both Bub2 and Mad2. (B) TEM1 over-expression allows DNA re-replication in mad2 mutant cells treated with nocodazole. Exponentially growing mad2Δ (K7292) and bub2Δmad2Δ (K7422) cells and mad2Δ cells containing an additional TEM1 gene expressed from the GAL promoter (K7765) were incubated in the presence of nocodazole (15 μg/ml) and the cellular DNA content was analysed at the time points indicated after nocodazole addition. TEM1 over-expression, induced immediately after nocodazole treatment, allowed mad2 mutant cells to re-replicate their DNA despite the Bub2 checkpoint activity. (C) The budding yeast homologue of the S.pombe gene byr4 ϩ is part of the Bub2 checkpoint pathway. Exponentially growing cells of bub2Δmad2Δ (K7764), byr4Δ (K8156) and byr4Δmad2Δ (K8157) were treated with nocodazole and the cellular DNA content was analysed at the time points indicated after nocodazole addition. Deletion of BYR4 causes the same efficient DNA re-replication in mad2 mutants as does deletion of BUB2.
Discussion
In the presence of lagging chromosomes or damaged spindles, most eukaryotic cells block separation of sister chromatids, inactivation of cyclin B-Cdk1 kinases, cytokinesis and chromosome re-duplication. They in effect arrest the cell cycle in a metaphase-like state. The existence of mad and bub mutants that fail to arrest the cell cycle under these circumstances suggested that specific 'surveillance mechanisms' or 'checkpoints' block the metaphase to anaphase transition when they detect chromosomes that have not formed bivalent attachments to the mitotic spindle. A resemblance between the mitotic arrest caused by lagging chromosomes or damaged spindles and that of mutants with defective APC subunits suggested that APC inhibition might be the means by which mitotic surveillance proteins block cell cycle progression.
Because of the belief that mad and bub mutants are defective in all aspects of the cell cycle arrest induced by spindle damage, it was supposed that these proteins might all be involved in a single pathway whose purpose was simply to inhibit the APC. However, it has recently become apparent that different APC substrates are degraded with the help of two different activators, WD40 proteins called Cdc20 and Cdh1. This raises the possibility that the two different forms of the APC, APC Cdc20 and APC Cdh1 , might be differently regulated.
Two distinct regulatory pathways regulate anaphase and mitotic exit
We show here that cell cycle arrest caused by disassembly of mitotic spindles in yeast can only be understood if we suppose that two distinct mitotic regulatory pathways exist (Figure 10 ). One pathway involving Mad1, Mad2, Mad3 and Bub1 inhibits APC Cdc20 , which blocks proteolysis of Pds1 and thereby prevents activation of the sister separating protein Esp1. This then is the mechanism by which cells block sister chromatid separation. In addition to inhibiting Esp1, Pds1 also blocks the onset of proteolysis mediated by the second APC activator, Cdh1. However, APC Cdh1 (and proteolysis of the B-type cyclin-Cdk1 inhibitor Sic1) is also regulated by a second, quite separate pathway whose function depends on Bub2. Due to this Bub2 pathway, cells lacking either Mad2 or Pds1 or even both proteins still arrest with high Clb2-Cdk1 kinase Fig. 10 . A model proposing two surveillance pathways that respond to spindle damage. Mad2 and Bub2 function in different pathways and block distinct cell cycle events in response to nocodazole treatment. The 'Mad2' pathway, which involves Mad1, Mad2, Mad3 and Bub1, inhibits APC Cdc20 and thereby blocks Pds1 degradation and sister chromatid separation. This pathway also blocks degradation of Clb3 by APC Cdc20 . Pds1 has a second role, which is to block Clb2 degradation and Sic1 accumulation (it is not clear which is the actual target of Pds1 in this respect). The 'Bub2' pathway, which also includes Byr4, blocks cytokinesis and DNA re-replication by preventing inactivation of mitotic Cdk1 kinases, principally Clb2-Cdk1. We propose that Bub2 and Byr4 promote GTP hydrolysis by Tem1, which prevents accumulation of the GTP-bound Tem1 needed (by an unknown mechanism) for Cdc14 phosphatase activity. Cdc14 is possibly needed to de-phosphorylate and thereby 'activate' Cdh1, Swi5 and Sic1. It is proposed that Clb3 is degraded by both APC Cdc20 and APC Cdh1 . See text for further details.
activity. Only when cells lack both Mad2-and Bub2-dependent pathways, as in bub2mad2 double mutants, do cells fully disregard spindle poisons such as nocodazole and charge through mitosis and enter the next cell cycle as if nothing were amiss.
We, and others before us (Hoyt et al., 1991; Minshull et al., 1996) , have noticed that inactivation of either the Mad2 or the Bub2 pathway permits cells to exit mitosis after arrest for between one and two generation times. Both pathways are therefore required to maintain an indefinite mitotic arrest in yeast. This does not detract from the significance of our finding that Mad2 and Bub2 are largely concerned with blocking different aspects of the cell cycle. It is not unlikely that many, if not most, instances of cell cycle arrest encountered by cells are short in duration. Indeed, many if not most mammalian cells are only capable of arresting exit from mitosis for very limited periods of time.
Pds1's role in arresting the cell cycle Until now the role of Pds1 has been one of the more confusing aspects of mitotic control in yeast. On the one hand, Pds1 clearly had a role in preventing the eventual separation of sister chromatids, in at least some cells treated with nocodazole (Yamamoto et al., 1996) . On the other hand, Pds1 was not required for blocking inactivation of Cdk1 kinase (Yamamoto et al., 1996) . These observations were difficult to reconcile with the model of a single regulatory pathway. However, they can be easily explained in the light of the scheme outlined in Figure 10 .
Our finding that Scc1 dissociates from chromosomes with the same kinetics in pds1 mutants in the presence of nocodazole as it does in the absence of this drug implies that Pds1 is crucial for delaying the loss of sister chromatid cohesion when spindles are damaged. Furthermore, we show for the first time that Mad2 is essential for delaying proteolysis of Pds1. These observations, along with the knowledge that Pds1 is an APC Cdc20 substrate (Visintin et al., 1997; Shirayama et al., 1998) , that Mad proteins bind to APC Cdc20 (Fang et al., 1998; Hwang et al., 1998) , that certain CDC20 mutants cause a bypass of Mad2-dependent cell cycle arrest Schott and Hoyt, 1998) and that Pds1 binds the sister separating protein Esp1 , suggest that Mad proteins and Pds1 occupy very different places in a pathway concerned with blocking sister separation (see Figure 10 ). By binding to and inhibiting APC Cdc20 , Mad2 blocks the proteolysis of several proteins normally degraded by this form of the APC. This includes Clb3 ( Figure 5D ) and Clb5 (data not shown), in addition to Pds1. It is, however, the persistence of Pds1, and Pds1 alone, that is responsible for blocking sister separation, by tying up Esp1 in an inactive complex. Unlike Mad2, Pds1 is not required for blocking Clb3 proteolysis. This suggests that Pds1 is not required for the direct inhibition of APC Cdc20 . According to this scheme, the outlines of which were first proposed as a speculative model by Yamamoto et al. (1996) , Pds1 clearly lies 'downstream' of the Mad proteins in a pathway that blocks sister separation in response to spindle damage. Two pieces of evidence support the notion that Pds1 has a second role, which is to block APC Cdh1 (and accumulation of Sic1). First, non-degradable versions of Pds1 block Clb2 proteolysis in addition to sister separation. Secondly, and more importantly, the block to Clb2 proteolysis that persists in bub2 mutants treated with nocodazole depends on PDS1. This property of Pds1 provides a mechanism by which the Mad2 pathway inhibits APC Cdh1 as well as APC Cdc20 .
Mad2 is not required to delay Clb2-Cdk1 inactivation
The proposal that Bub2 acts in a separate pathway to Mad2 hinges on our observation that mad2 mutants delay inactivation of Clb2-Cdk1 kinase and DNA re-replication for a period that corresponds to at least one generation time. Although our conclusions are novel, many of our observations on the behaviour of mad2 mutants are in fact consistent with previously published data. Other studies have noted the failure of mad2 mutants to maintain high levels of Cdk1 kinase activity (Li and Murray, 1991) . Our finding along with that of Minshull et al. (1996) , that mad2 mutants cannot block the degradation of Clb3 (and Clb5), accounts for the drop in Cdk1 kinase activity. Furthermore, the Mad2 pathway clearly does help to maintain Clb2-Cdk1 kinase at high levels in cells treated with nocodazole, presumably through its indirect effect on Clb2 and Sic1 proteolysis via Pds1. This effect is possibly of biological significance, because a small fraction of mad2 mutant cells do manage to exit from a mitotic state and re-replicate their genomes in the presence of nocodazole. The failure of other studies to notice the persistence of a mechanism which delays Clb2-Cdk1 inactivation in mad2 mutants lies less with primary observations than in their interpretation. The use of induction synchrony, which generates cells much larger than normal, possibly reduces but does not eliminate the effect. Mad2 mutants do indeed re-replicate, albeit inefficiently, after long periods of incubation in nocodazole during which cells become very large. Cell size is a crucial factor in all cell cycle studies and many cell cycle blocks are overcome by the growth of cells. Earlier studies have ignored the persistence of significant levels of Clb2-Cdk1 kinase activity in mad2 mutants incubated in the presence of nocodazole.
Bub2 blocks the cell cycle in mad2 mutants
Our ability to observe a robust cell cycle arrest in mad2 mutants enabled us to investigate properly for the first time the role of Bub2 in blocking mitotic exit. The nocodazole-induced cell cycle arrest of mad2 mutants is totally abolished by deletion of BUB2 but not by that of BUB1, MAD1 or MAD3. Our finding that cells only rereplicate efficiently in the presence of nocodazole if BUB2 is deleted along with either MAD1, MAD2, MAD3 or BUB1 implies that Mad1, Mad2, Mad3 and Bub1 function in one pathway and Bub2 in another.
Bub2's mode of action
Several questions can be raised about the role of Bub2 in arresting the cell cycle. How does Bub2 mediate cell cycle arrest, what physiological process does it aim to prevent, and what sort of defects might it be responding to? Bub2 is not required for blocking Pds1 proteolysis due to APC Cdc20 , but it is essential, in the absence of Pds1, for blocking proteolysis of Clb2 and Cdc5 (data not shown). These proteins are degraded by APC Cdh1 , which implies that APC Cdh1 might be one of Bub2's targets. Cdh1's ability to bind to the APC, crucial for Clb2 ubiquitination, is inhibited by phosphorylation of Cdh1 by Cdk1 . Given the high levels of Clb2-Cdk1 kinase in mad2 mutants arrested by nocodazole, we suspect that Cdh1 is hyper-phosphorylated and cannot therefore bind to the APC. If so, Bub2 must be necessary for preventing Cdh1 de-phosphorylation when spindles are damaged by nocodazole.
Bub2's role cannot, however, be confined to blocking Cdh1 de-phosphorylation, because mad2 mutant cells also fail to accumulate the kinase inhibitor Sic1 as indicated by the maintenance of high Clb2-Cdk1 kinase activity. This could be achieved by an inhibition of SIC1 transcription and persistent Sic1 proteolysis, both mediated by Clb2-Cdk1 (Moll et al., 1991; Knapp et al., 1996; Verma et al., 1997) . The former could be due to a failure to dephosphorylate the transcription factor Swi5 and the latter due to a failure to de-phosphorylate Sic1. Thus, Bub2 possibly prevents inactivation of Clb2-Cdk1 kinases by blocking de-phosphorylation of at least three proteins: Cdh1, Sic1 and Swi5.
One mechanism by which cells might normally escape from a self-sustaining high cyclin B-Cdk1 state would be to activate a phosphatase capable of de-phosphorylating Cdh1, Sic1 and Swi5. Cdc14 is a candidate for such a phosphatase. It is required for inactivating Clb2-Cdk1 and promoting Swi5 entry into nuclei during telophase and it has recently been shown to be capable of de-phosphorylating Swi5 and Sic1 in vitro (Visintin et al., 1998) . We noticed, furthermore, that the re-replication of bub2mad2 double mutants in the presence of nocodazole is abolished in cdc14 mutants. We propose therefore that Bub2 acts by inhibiting activation of Cdc14, which would fully explain its maintenance of Clb2-Cdk1 kinase.
The sequence of Bub2 provides a clue as to how it might affect Cdc14. Bub2 shares sequence similarity with Cdc16, a GTPase-activating protein (GAP) that is required for regulating septum formation in S.pombe (Fankhauser et al., 1993) . Bub2 is also homologous to two other GAPs from budding yeast, Gyp6 and Gyp7 (Neuwald, 1997) . Cdc16 together with Byr4 form a two-component GAP for the Spg1 GTPase (Furge et al., 1998) , which promotes septum formation (Schmidt et al., 1997 ). Spg1's S.cerevisiae homologue is a GTPase called Tem1, which is required along with Cdc14 for cytokinesis and exit from mitosis in budding yeast (Wan et al., 1992; Shirayama et al., 1994; Jaspersen et al., 1998) . We therefore propose that activation of Cdc14 depends on a GTP-bound form of Tem1 and that when spindles are damaged, Bub2 activates Tem1 GTP hydrolysis, prevents accumulation of Tem1 in a GTP-bound form, and thereby inhibits Cdc14 activation. This hypothesis is consistent with our observation that Tem1 overproduction bypasses the Bub2-dependent block of DNA re-replication in mad2 mutants treated with nocodazole. The existence of similar pathways which regulate cytokinesis and chromosome re-duplication in S.pombe and S.cerevisiae is further supported by identification of the budding yeast homologue of Byr4, which has a role similar to Bub2 in the cell cycle arrest induced by spindle damage. The main difference between the S.pombe genes, cdc16 ϩ and byr4 ϩ , and their counterparts in the budding yeast resides in the fact that the former are needed for regulating cytokinesis during undisturbed cell cycles and, therefore, they are essential genes (Fankhauser et al., 1993; Song et al., 1996) , while the latter seem to be required only for the spindle checkpoint activity and they are not essential.
Regarding the physiological process regulated by Bub2 in response to spindle damage, we conclude that, unlike Mad2, Bub2 is not concerned with blocking sister chromatid separation, but rather the onset of cytokinesis and chromosome re-replication.
It is currently unclear what sort of defects the Bub2 pathway normally detects. Previous data suggesting that Bub2 is not required for mitotic arrest induced by low concentrations of nocodazole or by kinetochore mutants (Wang and Burke, 1995) , indicate that the Bub2 pathway might not monitor spindle-kinetochore attachment but another defect caused by microtubule depolymerization such as the integrity of pole to pole spindles. Alternatively, the Bub2 pathway might detect spindle problems occurring after anaphase onset. A delay in cytokinesis could help chromatids not properly attached to the spindle to reach opposite poles of the cell. Bub2 could also monitor the integrity of cytoplasmic microtubules required for spindle orientation and nuclear positioning (Jacobs et al., 1988) . Consistent with such a possibility, Bub2 was found to localize throughout the cell (M.Shirayama, personal communication).
Clb2, a late mitotic cyclin that regulates cytokinesis Our observation that Clb3 is degraded in mad2 mutants but not in pds1 mutants in the presence of nocodazole can best be explained if the bulk of Clb3 were degraded by APC Cdc20 . Other data clearly demonstrate, however, that during G 1 Clb3 is degraded by APC Cdh1 . We propose that Clb3 may be a substrate for both APC Cdc20 and APC Cdh1 (see Figure 10) . Thus, Clb3 degradation would be initiated by APC Cdc20 as cells enter anaphase and then taken over by APC Cdh1 . Clb2, on the other hand, can only be degraded by APC Cdh1 . In this regard, Clb3 behaviour resembles more closely the behaviour of B-type cyclins in animal cells than that of Clb2. This raises a question as to why yeast cells choose to delay Clb2 degradation until well after anaphase has been initiated. Its persistence might be important for preventing the premature onset of cytokinesis, which could be a problem peculiar to budding yeast cells that make many of the preparations for cell division very early in the cell cycle, when for example they generate septin rings at the bud neck soon after the initiation of DNA replication.
Materials and methods
Yeast strains and growth conditions
All strains were derivatives of W303 (also called K699: MATa ho ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3 ssd1) . Cells were grown in YEP medium (1% yeast extract, 2% bactopeptone, 50 mg/l adenine) containing either 2% raffinose (YEPRaf) or 2% glucose (YEPD) . To obtain synchronous cultures, cells were grown in YEPRaf medium at 25°C (or at 19°C in the case of pds1Δ strains) and small G 1 cells were isolated by centrifugal elutriation (Schwob and Nasmyth, 1993) . G 1 cells were inoculated into YEPD medium at 25°C to a density of 7ϫ10 6 cells/ml. Nocodazole was diluted into the medium to a final concentration of 15 μg/ml from a stock solution of 10 mg/ml in dimethylsulfoxide. GAL-MPS1 strains were grown in YEPRaf medium at 21°C and the GAL promoter was pre-induced for 90 min by adding 3% galactose prior to elutriation. Small G 1 cells were released at 25°C into YEPRaf medium containing 3% galactose. For the experiment shown in Figure 5F , cells were arrested in G 1 at 25°C by incubation with α-factor (2.5 μg/ml) for 150 min and then released in medium containing nocodazole (15 μg/ml) and lacking α-factor. To induce TEM1 expression from the GAL promoter, 2% galactose was added to a culture pregrown in YEPRaf.
Strain constructions
Strains containing Myc-tagged versions of SCC1, PDS1 and CLB2 have been described (Zachariae et al., 1996; Michaelis et al., 1997; Shirayama et al., 1998) . The BUB1 and BUB2 ORFs were replaced by cassettes containing the S.pombe his5 ϩ gene which complements his3 mutations in budding yeast. These cassettes were amplified by PCR with target gene-specific primers from pFA6a-HIS3MX6 (Wach et al., 1997) and transformed into yeast. The MAD2, MAD3 and BYR4 ORFs were replaced with cassettes containing the Kluyveromyces lactis TRP1 gene. The mad2 deletion strain used in Figure 5 was constructed using a mad2::URA3 plasmid kindly provided by A.Murray. MAD1 was disrupted by transformation with a mad1::URA3 plasmid (Hardwick and Murray, 1995) . The GAL-MPS1 strain was described previously (Hardwick et al., 1996) . The strain K8107 was constructed by transforming a cdc20 deletion strain, kept alive by a plasmid bearing a GAL promoter-driven CDC20 gene (Lim et al., 1998) with the HindIII fragment of a pCM4-derived plasmid carrying the CDC20-107 allele , followed by selection of colonies which lost the GAL-CDC20 centromeric plasmid. GAL-TEM1 construct (Shirayama et al., 1994) was integrated into the genome of the strain K7747 at the ura3 locus. Genetic crosses and transformation of yeast strains were carried out according to standard protocols (Sherman et al., 1974) .
Immunoblot analysis and histone H1 kinase assay
Protein immunoblot analysis was performed as described (Surana et al., 1993) . After transfer to Immobilon P membranes (Millipore), proteins were detected using an enhanced chemiluminescence detection system (ECL, Amersham). Clb2 and Cdc28 were detected using polyclonal rabbit antisera diluted 1:3000. Rabbit affinity-purified Clb3 antibodies (kindly provided by D.Kellogg) were used at a dilution of 1:1500. In experiments in which both Western blotting and H1 kinase assays were performed, the extracts prepared for the kinase assay were also used for Western blotting. Histone H1 kinase assays were performed as described previously (Surana et al., 1993) . Phosphorylated histone H1 was detected by autoradiography and quantified with a Molecular Dynamics PhosphoImager using the ImageQuant software.
Other techniques
The DNA content of cells stained with propidium iodide was measured on a Becton Dickinson FACScan flow cytometer as described (Epstein and Cross, 1992) . Chromosomes were visualized in cells expressing a tet repressor-GFP fusion protein which binds to an array of tet operators integrated at the ura3 locus, 35 kb from the centromere of chromosome V (Michaelis et al., 1997) . Chromosome spreading and visualization of yeast chromosomes using the tetR-GFP/tet operators system were performed as described previously (Michaelis et al., 1997) . Cells were prepared for indirect immunofluorescence according to Nasmyth et al. (1990) . Myc-tagged proteins were detected using 9E10 hybridoma supernatant diluted 1:5 and a CY3-conjugated secondary antibody. Spindles were detected using a rabbit anti-yeast tubulin antibody and a FITC-conjugated secondary antibody. DNA was stained with DAPI.
